Clondalkin Group signs agreement with Pharma Prospect

Aims to extend its pharma and healthcare business across Europe

Pharma and healthcare packaging specialist Clondalkin Group has joined forces with Pharma Prospect in Spain in a strategic alliance to develop and strengthen its pharma and healthcare business across Europe.

Pharma Prospect, located in Barcelona, manufactures printed paper leaflets which are supported by extensive design, pre-press, supply chain management and packaging services.

Clondalkin Sales and Marketing Director Malcolm Farnan said the firm was pleased to form this marketing agreement.

'Pharma Prospect specialises in the manufacture of print solutions to some of the world's leading manufacturers in the pharmaceutical, medical device, healthcare and cosmetic industries and therefore complements our own capabilities perfectly. Like us, they focus on providing innovative, value-added packaging solutions and developing strong and long-lasting customer relationships.'

He added: 'By working together and effectively promoting each other's skills and expertise, the agreement will enable both parties to realise new opportunities and strengthen our growth strategies in Europe.'

Clondalkin's Pharma & Healthcare division is a global supplier of cartons, labels and literature and operates 17 sites throughout North America and Europe, including a carton operation in Spain formerly known as Cartonplex, which is also based in Barcelona.

Clondalkin Group's Pharma & Healthcare Global CEO, David Lennon, concluded: 'This alliance with Pharma Prospect is part of our stated objective to become the global leader in the supply of secondary packaging to the Pharma & Healthcare sector.'

Companies